European Innovation Council

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

David Malo Jean

Director

Past deals in Real Time

Quantune Technologies

Grant in 2024
Quantune is a deep tech startup specializing in optics and photonics technology. The company develops a compact infrared spectrometer that miniaturizes traditional laboratory equipment for molecular analysis, making it accessible for both biomedical consumer devices and industrial applications. This innovative spectrometer facilitates continuous and non-invasive health monitoring, allowing clients to achieve real-time monitoring and analysis of chemical compounds and emissions. By transforming large-scale laboratory processes into a portable module, Quantune enables novel applications in various fields, enhancing the capabilities of health and environmental monitoring.

DTE ehf

Series A in 2023
DTE introduces breakthrough real-time process control analytics for metals production and processing towards Industry 4.0, through our robotic hardware and software solutions, automating current manual sampling processes for improved quality, cost, efficiency and safety.

Quantune Technologies

Grant in 2023
Quantune is a deep tech startup specializing in optics and photonics technology. The company develops a compact infrared spectrometer that miniaturizes traditional laboratory equipment for molecular analysis, making it accessible for both biomedical consumer devices and industrial applications. This innovative spectrometer facilitates continuous and non-invasive health monitoring, allowing clients to achieve real-time monitoring and analysis of chemical compounds and emissions. By transforming large-scale laboratory processes into a portable module, Quantune enables novel applications in various fields, enhancing the capabilities of health and environmental monitoring.

Sightic

Pre Seed Round in 2022
Sightic Analytics specializes in developing AI-powered software that enables real-time analysis of drug effects through image analysis of the eye area. Utilizing a mobile phone's camera, the company's technology captures a short film sequence of an individual's eye, focusing on pupil responses to detect the presence of drugs. This innovative approach allows for efficient and discreet drug testing, making it suitable for use in various settings, including workplace environments. Sightic's solution aims to streamline the drug screening process while minimizing privacy concerns, enabling employers to monitor employee health effectively.

Afon Technology

Grant in 2022
Afon Technology specializes in developing non-invasive blood glucose monitoring devices aimed at improving the management of diabetes. Their innovative technology allows users to convert any smartwatch into a glucose monitoring device that provides real-time tracking of blood glucose levels, including high and low alerts. The devices offer fast and accurate measurements, data logging, and personalized health trend analysis, which help users monitor their condition effectively. Additionally, Afon Technology's solutions feature Bluetooth connectivity to smart devices, enabling compatibility with both iOS and Android platforms. This user-friendly approach enhances the quality of daily diabetes management and helps reduce the risk of complications associated with the condition.

BlinkIn

Grant in 2022
BlinkIN is a developer of a smart visual assistant designed to enhance customer support through an innovative visual bot. This tool functions similarly to a virtual assistant, guiding users through technical troubleshooting by allowing them to show their devices via smartphone. It provides step-by-step solutions augmented on the user's screen while confirming the accuracy of each step. Additionally, BlinkIN offers BlinkIN Expert, a support tool that utilizes augmented reality and artificial intelligence to transform traditional audio tech support into a more interactive and efficient visual experience. This service connects experts with customers or local technicians through a simple SMS link, requiring no installation. By leveraging these technologies, BlinkIN aims to streamline customer support processes and reduce the need for in-person service dispatches.

IRUBIS

Convertible Note in 2022
IRUBIS GmbH, founded in 2017 and based in Munich, Germany, specializes in the development of mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company focuses on enhancing Fourier transform infrared (FTIR) spectroscopy to improve the analysis of protein-based drugs. Its innovative measurement systems enable real-time bioreactor monitoring, allowing for the online assessment of glucose and lactate levels without contamination risks. IRUBIS also produces a range of ATR crystals, including single-reflection and signal-enhanced varieties, aimed at advancing industry standards for bioprocess monitoring. The company’s technology supports both upstream and downstream bioprocessing, facilitating metabolite monitoring and the detection of target proteins and contaminants through machine-learning evaluation software.

IRUBIS

Seed Round in 2022
IRUBIS GmbH, founded in 2017 and based in Munich, Germany, specializes in the development of mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company focuses on enhancing Fourier transform infrared (FTIR) spectroscopy to improve the analysis of protein-based drugs. Its innovative measurement systems enable real-time bioreactor monitoring, allowing for the online assessment of glucose and lactate levels without contamination risks. IRUBIS also produces a range of ATR crystals, including single-reflection and signal-enhanced varieties, aimed at advancing industry standards for bioprocess monitoring. The company’s technology supports both upstream and downstream bioprocessing, facilitating metabolite monitoring and the detection of target proteins and contaminants through machine-learning evaluation software.

Sightic

Grant in 2022
Sightic Analytics specializes in developing AI-powered software that enables real-time analysis of drug effects through image analysis of the eye area. Utilizing a mobile phone's camera, the company's technology captures a short film sequence of an individual's eye, focusing on pupil responses to detect the presence of drugs. This innovative approach allows for efficient and discreet drug testing, making it suitable for use in various settings, including workplace environments. Sightic's solution aims to streamline the drug screening process while minimizing privacy concerns, enabling employers to monitor employee health effectively.

Stream Analyze

Grant in 2022
Stream Analyze develops an innovative analytic engine designed to enhance efficiency and performance in data processing. The company focuses on real-time analytics and event processing, allowing users to quickly identify anomalies in data flows and manage extensive data operations. Its edge artificial intelligence platform simplifies the development, deployment, and management of machine learning models, making it accessible even on low-computing devices like microcontroller units. By processing various data types directly at the source, Stream Analyze enables faster responses to data queries while minimizing bandwidth usage and costs. This approach empowers customers to achieve timely insights and improve decision-making processes.

DTE ehf

Venture Round in 2022
DTE introduces breakthrough real-time process control analytics for metals production and processing towards Industry 4.0, through our robotic hardware and software solutions, automating current manual sampling processes for improved quality, cost, efficiency and safety.

DTE ehf

Grant in 2022
DTE introduces breakthrough real-time process control analytics for metals production and processing towards Industry 4.0, through our robotic hardware and software solutions, automating current manual sampling processes for improved quality, cost, efficiency and safety.

Xsensio

Seed Round in 2021
Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

MYSPHERA

Venture Round in 2021
MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.

MYSPHERA

Grant in 2021
MYSPHERA SL is a company based in Paterna, Spain, that specializes in developing location and process visibility solutions for the healthcare sector using Internet of Things (IoT) technology and real-time location systems (RTLS). Established in 2012, MYSPHERA offers a range of IoT devices and applications designed to enhance patient care and operational efficiency in acute care hospitals, senior living facilities, and patient homes. Its solutions include tracking systems for residents and nursing services, as well as alerts for patients. The company also provides various web applications, such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare professionals and administrators in managing services effectively. By delivering actionable insights through smart sensors, MYSPHERA aims to improve patient outcomes and optimize resource management across healthcare organizations in Europe, the Middle East, and Latin America.

Mode Sensors

Venture Round in 2020
Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, established in 2016. It specializes in developing advanced wearable technology for real-time hydration monitoring, which is essential in various sectors, including healthcare, defense, and workforce safety. The company's flagship product, Re:Balans®, offers continuous and non-invasive tracking of fluid balance, allowing for early intervention in hydration-related issues. By integrating with existing remote patient monitoring systems, Mode Sensors supports a range of applications in hospitals, elderly care, military settings, and high-performance work environments. With a commitment to innovation and user-friendly design, Mode Sensors aims to enhance well-being and performance through effective hydration management.

Mode Sensors

Grant in 2020
Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, established in 2016. It specializes in developing advanced wearable technology for real-time hydration monitoring, which is essential in various sectors, including healthcare, defense, and workforce safety. The company's flagship product, Re:Balans®, offers continuous and non-invasive tracking of fluid balance, allowing for early intervention in hydration-related issues. By integrating with existing remote patient monitoring systems, Mode Sensors supports a range of applications in hospitals, elderly care, military settings, and high-performance work environments. With a commitment to innovation and user-friendly design, Mode Sensors aims to enhance well-being and performance through effective hydration management.

Xsensio

Venture Round in 2020
Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

Xsensio

Grant in 2020
Xsensio is a digital health company focused on addressing the challenge of real-time, continuous monitoring of health parameters. It is developing an innovative Lab-on-Skin wearable device that serves as a miniaturized sensing platform, enabling continuous and real-time analysis of biochemical information at the skin's surface. This technology allows for the precise measurement of various health indicators, such as electrolytes, metabolites, hormones, and proteins, akin to traditional blood tests but in a minimally invasive manner. By providing unprecedented insights during critical health events, Xsensio aims to enhance patient care and shift the healthcare industry from a static to a dynamic approach in health monitoring.

Cinfo

Seed Round in 2020
Cinfo specializes in providing cloud-based automated video production services for enterprises equipped with venues and broadband connections. The company deploys smart cameras at various locations to facilitate high-quality live or on-demand video broadcasting to mobile devices, web browsers, smart TVs, and VR devices. Its software automates production operations, allowing clients to efficiently manage recording, real-time production, and broadcasting. Cinfo's technology enhances the viewer experience through multi-camera setups and immersive virtual reality, while also offering valuable tools for sports organizations to analyze competitions and training. Additionally, the company has expanded its services to other sectors, including aeronautics, where it streams IoT data from unmanned aerial vehicles, and corporate environments, where it supports multi-country management and press conferences for major businesses. The adoption of Cinfo's technology by HbbTV broadcasters further underscores its versatility in creating engaging multi-camera experiences.

Cinfo

Grant in 2020
Cinfo specializes in providing cloud-based automated video production services for enterprises equipped with venues and broadband connections. The company deploys smart cameras at various locations to facilitate high-quality live or on-demand video broadcasting to mobile devices, web browsers, smart TVs, and VR devices. Its software automates production operations, allowing clients to efficiently manage recording, real-time production, and broadcasting. Cinfo's technology enhances the viewer experience through multi-camera setups and immersive virtual reality, while also offering valuable tools for sports organizations to analyze competitions and training. Additionally, the company has expanded its services to other sectors, including aeronautics, where it streams IoT data from unmanned aerial vehicles, and corporate environments, where it supports multi-country management and press conferences for major businesses. The adoption of Cinfo's technology by HbbTV broadcasters further underscores its versatility in creating engaging multi-camera experiences.

IRUBIS

Venture Round in 2020
IRUBIS GmbH, founded in 2017 and based in Munich, Germany, specializes in the development of mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company focuses on enhancing Fourier transform infrared (FTIR) spectroscopy to improve the analysis of protein-based drugs. Its innovative measurement systems enable real-time bioreactor monitoring, allowing for the online assessment of glucose and lactate levels without contamination risks. IRUBIS also produces a range of ATR crystals, including single-reflection and signal-enhanced varieties, aimed at advancing industry standards for bioprocess monitoring. The company’s technology supports both upstream and downstream bioprocessing, facilitating metabolite monitoring and the detection of target proteins and contaminants through machine-learning evaluation software.

IRUBIS

Grant in 2020
IRUBIS GmbH, founded in 2017 and based in Munich, Germany, specializes in the development of mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company focuses on enhancing Fourier transform infrared (FTIR) spectroscopy to improve the analysis of protein-based drugs. Its innovative measurement systems enable real-time bioreactor monitoring, allowing for the online assessment of glucose and lactate levels without contamination risks. IRUBIS also produces a range of ATR crystals, including single-reflection and signal-enhanced varieties, aimed at advancing industry standards for bioprocess monitoring. The company’s technology supports both upstream and downstream bioprocessing, facilitating metabolite monitoring and the detection of target proteins and contaminants through machine-learning evaluation software.

Ladimo

Grant in 2019
LaDiMo Oy, founded in 2015 and based in Espoo, Finland, specializes in developing the Ladimo Smarter Vision technology, a real-time 3D point cloud acquisition solution. The company builds upon innovative technology initially created at Aalto University in 2012 by Jorma Palmén. By integrating photogrammetry, laser technology, and mathematical modeling, Ladimo offers a novel approach to generating high-precision point cloud data. This technology is particularly applicable in machine vision fields, including collaborative robots, industrial automation, automated guided vehicles, and various virtual, augmented, and mixed reality applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.